ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 998

A Psychometric Analysis of the Social Interaction Anxiety Scale (SIAS-6) in Systemic Sclerosis: Results from the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort

Shadi Gholizadeh1, Sarah D. Mills2, Rina S. Fox2, Lisa Jewett3,4, Linda Kwakkenbos3,4, Marie-Eve Carrier5, Brett D. Thombs3,5, Scott C. Roesch2,6, Vanessa L. Malcarne2,6, Karen Gottesman7 and SPIN Investigators, 1Psychoogy, SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, 3McGill University, Montreal, QC, Canada, 4Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada, 5Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada, 6Psychology, San Diego State University, San Diego, CA, 7Scleroderma Foundation, Los Angeles, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Anxiety, patient-reported outcome measures, psychosocial and systemic sclerosis, Validity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: ARHP I: Exemplary Abstracts

Session Type: ARHP Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: The experience of living with a serious illness, such as systemic sclerosis (SSc), can pose challenges for an individual’s self-concept and social roles. This can necessitate new patterns of interacting with others, which may lead to social anxiety. Research on the social impacts of SSc is limited, and there are few validated measures in this area. The Social Interactions Anxiety Scale (SIAS-6) was developed to assess social interactional anxiety, or distress experienced when interacting with others. The instrument has demonstrated good measurement properties, but has not been tested in SSc. The present study has the following two aims: 1) to assess the reliability and validity of the SIAS-6 in a sample of SSc patients, and 2) to explore whether scores can be meaningfully compared across the limited and diffuse subtypes of the disease.  

Methods: Confirmatory factor analysis (CFA) was used to evaluate the structural validity of the one factor model of the SIAS-6 in sample of patients with SSc  (N = 596; 59.1% limited, 40.9% diffuse) enrolled in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. Multiple group confirmatory factor analysis (MGCFA) was used to evaluate the comparability of the factor structures of the SIAS-6 for patients with limited and diffuse disease subtypes. The MGCFA evaluated configural invariance (i.e., baseline model fitting a one-factor solution for both groups), metric invariance (i.e., factor loadings constrained to equivalence), and factor variance invariance (i.e., factor loadings and variances constrained to equivalence) models.  Internal consistency reliability was examined via Cronbach’s coefficient alpha. Convergent validity was examined via Pearson product-moment correlations with measures of depression, body image dissatisfaction/avoidance, fear of negative evaluation, and social anxiety.

Results: Per descriptive fit indices using CFA, a one-factor model was found to fit the data (Comparative Fit Index [CFI] = 0.99, Standardized Root Mean Residual [SRMR] = 0.02, Root Mean Square Error of Approximation [RMSEA] = 0.06). The MGCFA demonstrated that the metric invariance model best fit the data (i.e., equivalent factor loadings but different variances across disease groups) based on the descriptive indices of CFI, SRMR, and RMSEA; change in CFI; and the Satorra-Bentler X2 difference test. Internal consistency reliability was good for limited (α  = 0.86) and diffuse (α  = 0.92) groups. Convergent validity testing demonstrated significant, moderate to strong correlations in the expected directions with measures of depression (r = 0.48, p < .01), body image dissatisfaction, avoidance, and concerns (r = 0.51, r = 0.42, r = 0.54, respectively, all ps < .01), fear of negative evaluation (r = 0.57, p < .01), and social anxiety (r = 0.58, p < .01) in the total sample. 

Conclusion: The present study demonstrates that the SIAS-6 can be confidently used as a one-factor measure of social interaction anxiety in patients with both limited and diffuse subtypes of SSc.


Disclosure: S. Gholizadeh, None; S. D. Mills, None; R. S. Fox, None; L. Jewett, None; L. Kwakkenbos, None; M. E. Carrier, None; B. D. Thombs, None; S. C. Roesch, None; V. L. Malcarne, None; K. Gottesman, None.

To cite this abstract in AMA style:

Gholizadeh S, Mills SD, Fox RS, Jewett L, Kwakkenbos L, Carrier ME, Thombs BD, Roesch SC, Malcarne VL, Gottesman K. A Psychometric Analysis of the Social Interaction Anxiety Scale (SIAS-6) in Systemic Sclerosis: Results from the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/a-psychometric-analysis-of-the-social-interaction-anxiety-scale-sias-6-in-systemic-sclerosis-results-from-the-scleroderma-patient-centered-intervention-network-spin-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-psychometric-analysis-of-the-social-interaction-anxiety-scale-sias-6-in-systemic-sclerosis-results-from-the-scleroderma-patient-centered-intervention-network-spin-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology